Survival and Cost-Effectiveness of Trabectedin Compared to Ifosfamide Monotherapy in Advanced Soft Tissue Sarcoma Patients

Trabectedin and ifosfamide are among the few cytostatic agents active in advanced soft tissue sarcomas (STSs). Trabectedin is most potent against so-called L-sarcomas (leiomyosarcoma and liposarcoma). The survival gain and cost-effectiveness of these agents in a second-line setting were analysed in...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Sarcoma
Главные авторы: Verboom, Michiel C., Gelderblom, Hans, Kerst, J. Martijn, Steeghs, Neeltje, Reyners, Anna K. L., Sleijfer, Stefan, van der Graaf, Winette T. A., van den Hout, Wilbert B.
Формат: Artigo
Язык:Inglês
Опубликовано: Hindawi 2019
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6589299/
https://ncbi.nlm.nih.gov/pubmed/31281207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/3234205
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы